Merck says US CDC endorses cervical cancer vaccine
Key points
- Centers for Disease Control and Prevention has adopted the recommendation of an advisory panel that the drugmaker's vaccine against cervical cancer routinely be given to females aged 11 through 26.
- The recommendations for use of the Gardasil vaccine, which provides protection against two strains of the human papillomavirus responsible for most cases of cervical cancer, were issued by the FDA's Advisory Committee on Immunization Practices in June 2006.
Merck & Co. Thursday said the U.S. Centers for Disease Control and Prevention has adopted the recommendation of an advisory panel that the drugmaker's vaccine against cervical cancer routinely be given to females aged 11 through 26.
The recommendations for use of the Gardasil vaccine, which provides protection against two strains of the human papillomavirus responsible for most cases of cervical cancer, were issued by the FDA's Advisory Committee on Immunization Practices in June 2006.
"The guidelines state that routine vaccination with Gardasil is recommended for 11- and 12-year-old females and for females ages 13 to 26 who have not previously been vaccinated or who have not completed the full series, and that vaccination with Gardasil can be started at nine years of age," Merck said in a news release.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsGates backs cervical cancer vaccines for poor
Microsoft Corp founder Bill Gates is putting his financial muscle behind a campaign to get life-saving Cervical cancer vaccines to women in poor countries. Two rival vaccines targeting the Human papilloma virus (HPV),…
14 June 2005
NewsCervical cancer vaccine expected in a few years
A vaccine that could prevent young women from developing most cases of cervical cancer could be on the market within a few years. Researchers are testing dozens of vaccines against different types of cancer but those…
2 February 2005
NewsVaccine stops virus tied to cervical cancer
It's one of the most common cancers in women and kills about a quarter of a million patients each year, but scientists said on Friday that a new vaccine could prevent most cases of cervical cancer. The researchers…
